Malaysia

8 Vaccines Approved for Use in Malaysia

RNA

Moderna

Spikevax

Approved in 86 countries
63 trials in 22 countries
Approval Source: reuters.com
RNA

Pfizer/BioNTech

Comirnaty

Approved in 146 countries
80 trials in 26 countries
Approval Source: reuters.com
Non Replicating Viral Vector

CanSino

Convidecia

Approved in 10 countries
13 trials in 6 countries
Approval Source: reuters.com
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Approval Source: reuters.com
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 140 countries
63 trials in 30 countries
Approval Source: covid-19.moh.gov.my
Inactivated

Bharat Biotech

Covaxin

Approved in 14 countries
13 trials in 2 countries
Approval Source: nst.com.my
Inactivated

Sinopharm (Beijing)

Covilo

Approved in 91 countries
29 trials in 12 countries
Approval Source: macaubusiness.com
Inactivated

Sinovac

CoronaVac

Approved in 56 countries
37 trials in 9 countries
Approval Source: reuters.com

2 in Clinical Trials in Malaysia

Non Replicating Viral Vector

ReiThera

GRAd-COV2

5 trials in 12 countries
Inactivated

Chinese Academy of Medical Sciences

Inactivated (Vero Cells)

8 trials in 4 countries